IACP Names Cynthia Blankenship, Esq., Vice President Government Affairs
New VP to Play Integral Role in Leading the Academy’s Legislative Efforts
Washington, D.C. – The International Academy of Compounding Pharmacists (IACP) has named Cynthia E. Blankenship, Esq., as its new Vice President of Government Affairs.
In her new IACP role, Blankenship serves as primary contact for Congress, federal and state regulatory agencies and other interests concerning IACP policies and activities associated with its advocacy efforts. Additionally, Ms. Blankenship manages IACP’s Political Action Committee (COMP-PAC) and directly oversees compliance with the Federal Election Commission related federal election laws. Ms. Blankenship works with IACP governance committees and other internal groups to develop a comprehensive strategy and approach to address the legislative and regulatory issues and concerns to compounding pharmacists; and, continually strives to increase the involvement and awareness of IACP and its members in these areas. Ms. Blankenship also is IACP’s point of contact with outside organizations and affiliations on matters of policy affecting compounding pharmacists and their practices.
“I'm looking forward to working with this important sector of the pharmacy profession—the compounding pharmacist,” Blankenship said. “The compounding pharmacist’s ability to individualize medications that ensures the most appropriate dose and delivery system improves compliance, adherence and overall patient health outcomes. The provision of personalized medication solutions is the epitome of a patient-centric approach to health care.”
Blankenship brings to IACP a wealth of experience in the pharmacy association, legislative, legal and federal and state agency settings. She is a Magna Cum Laude graduate of both the University of Central Arkansas and the University of Miami School of Law. She was the Senior Policy Advisor for U.S. House of Representative Marion Berry, and the Legislative Assistant for House Committee on Veterans’ Affairs Portfolio, Health, and Appropriations for U.S. House of Representative Tim Walz. Additional experience includes positions with Senator Blanche Lincoln, the Equal Employment Opportunity Commission and the Supreme Court of Arkansas.
Most recently, Blankenship was the Director of Policy and Regulatory Affairs at the National Community Pharmacists Association (NCPA) where she was responsible for drafting formal comments to all Federal rulemaking efforts including Federal Notice of Proposed Rulemaking, Federal Requests for Comment, and Federal Final Rules. In this role, Blankenship also educated all Members on all Federal legal and policy changes impacting businesses and pharmacy, and maintained daily contact with Federal agencies, the U.S. Senate, the U.S. House, Members and other organizations.
The International Academy of Compounding Pharmacists (IACP) is an association representing more than 3,600 pharmacists, technicians, students, and members of the compounding community who focus upon the specialty practice of pharmacy compounding. Compounding pharmacists work directly with prescribers including physicians, nurse practitioners and veterinarians to create customized medication solutions for patients and animals whose healthcare needs cannot be met by manufactured medications. More than 164,000 patients and prescribers also belong to our organization via the grassroots advocacy group, P2C2 (Patients and Professionals for Customized Care). IACP's mission of protecting, promoting and advancing personalized medication solutions is critical for patient healthcare. Visit www.iacprx.org to learn more and to find a compounding pharmacist near you.